| Home > Zentren > Zentrum für Operative Medizin > Klinik und Poliklinik für Urologie > Publikationen 2010
Auprich M, Haese A, Walz J, Pummer K, de la Taille A, Graefen M, de Reijke T, Fisch M, Kil P, Gontero P, Irani J, Chun FK.
External Validation of Urinary PCA3-Based Nomograms to Individually Predict Prostate Biopsy Outcome.
Eur Urol. 2010 Jul 3.
Schwarzenbach H, Chun FK, Isbarn H, Huland H, Pantel K.
Genomic profiling of cell-free DNA in blood and bone marrow of prostate cancer patients.
J Cancer Res Clin Oncol. 2010 Aug 4.
Schlomm T, Chun FKH, Erbersdobler A.
From Gene to Clinic: TMA-Based Clinical Validation of Molecular Markers in Prostate Cancer.
Methods Mol Biol. 2010;664:177-89.
Rink M, Chun FK, Minner S, Friedrich M, Mauermann O, Heinzer H, Huland H, Fisch M, Pantel K, Riethdorf S.
Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer.
BJU Int. 2010 Aug 24.
Chun FK, Epstein JI, Ficarra V, Freedland SJ, Montironi R, Montorsi F, Shariat SF, Schröder FH, Scattoni V.
Optimizing Performance and Interpretation of Prostate Biopsy: A Critical Analysis of the Literature.
Eur Urol. 2010 Sep 4.
Huang Y, Isharwal S, Haese A, Chun FK, Makarov DV, Feng Z, Han M, Humphreys E, Epstein JI, Partin AW, Veltri RW.
Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason score.
BJU Int. 2010 Sep 28. doi: 10.1111/j.1464-410X.2010.09692.x.
Lughezzani G, Sun M, Perrotte P, Alasker A, Jeldres C, Isbarn H, Budäus L, Lattouf JB, Valiquette L, Bénard F, Saad F, Graefen M, Montorsi F, Karakiewicz PI.
Comparative study of inguinal hernia repair rates after radical prostatectomy or external beam radiotherapy.
Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1307-13. Epub 2010 Apr 8.PMID: 20381269
Budäus L, Abdollah F, Sun M, Morgan M, Johal R, Thuret R, Zorn KC, Isbarn H, Shariat SF, Montorsi F, Perrotte P, Graefen M, Karakiewicz PI.
Annual surgical caseload and open radical prostatectomy outcomes: improving temporal trends.
J Urol. 2010 Dec;184(6):2285-90. Epub 2010 Oct 16.PMID: 20952010
Mehnert A, Lehmann C, Graefen M, Huland H, Koch U.
Depression, anxiety, post-traumatic stress disorder and health-related quality of life and its association with social support in ambulatory prostate cancer patients.
Eur J Cancer Care (Engl). 2010 Nov;19(6):736-45. doi: 10.1111/j.1365-2354.2009.01117.x.PMID: 19832893 [PubMed - in process]Related citations
Auprich M, Chun FK, Ward JF, Pummer K, Babaian R, Augustin H, Luger F, Gutschi S, Budäus L, Fisch M, Huland H, Graefen M, Haese A.
Critical Assessment of Preoperative Urinary Prostate Cancer Antigen 3 on the Accuracy of Prostate Cancer Staging.
Eur Urol. 2010 Oct 20. PMID: 20980098
Budäus L, Sun M, Abdollah F, Zorn KC, Morgan M, Johal R, Liberman D, Thuret R, Isbarn H, Salomon G, Haese A, Montorsi F, Shariat SF, Perrotte P, Graefen M, Karakiewicz PI.
Impact of Surgical Experience on In-Hospital Complication Rates in Patients Undergoing Minimally Invasive Prostatectomy: A Population-Based Study.
Ann Surg Oncol. 2010 Oct 16. PMID: 20953720
Steuber T, Budäus L, Walz J, Zorn KC, Schlomm T, Chun F, Ahyai S, Fisch M, Sauter G, Huland H, Graefen M, Haese A.
Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
BJU Int. 2010 Oct 13. doi: 10.1111/j.1464-410X.2010.09730.x. PMID: 20942833
Budäus L, Graefen M, Salomon G, Isbarn H, Lughezzani G, Sun M, Chun FK, Schlomm T, Steuber T, Haese A, Koellermann J, Sauter G, Fisch M, Heinzer H, Huland H, Karakiewicz PI.
The novel nomogram of Gleason sum upgrade: possible application for the eligible criteria of low dose rate brachytherapy.
Int J Urol. 2010 Oct;17(10):862-8. doi: 10.1111/j.1442-2042.2010.02615.x. Epub 2010 Aug 31.PMID: 20812920
Budäus L, Isbarn H, Eichelberg C, Lughezzani G, Sun M, Perrotte P, Chun FK, Salomon G, Steuber T, Köllermann J, Sauter G, Ahyai SA, Zacharias M, Fisch M, Schlomm T, Haese A, Heinzer H, Huland H, Montorsi F, Graefen M, Karakiewicz PI.
Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stage.
J Urol. 2010 Oct;184(4):1341-6. Epub 2010 Aug 17.PMID: 20723925
Crépel M, Jeldres C, Sun M, Lughezzani G, Isbarn H, Alasker A, Capitanio U, Shariat SF, Arjane P, Widmer H, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.
A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
Urology. 2010 Oct;76(4):883-8.PMID: 20932408
Walz J, Joniau S, Chun FK, Isbarn H, Jeldres C, Yossepowitch O, Chao-Yu H, Klein EA, Scardino PT, Reuther A, Poppel HV, Graefen M, Huland H, Karakiewicz PI.
Pathological results and rates of treatment failure in high-risk prostate cancer patients after radical prostatectomy.
BJU Int. 2010 Sep 28. doi: 10.1111/j.1464-410X.2010.09594.x. PMID: 20875089
Abdollah F, Sun M, Thuret R, Budäus L, Jeldres C, Graefen M, Briganti A, Perrotte P, Rigatti P, Montorsi F, Karakiewicz PI.
Decreasing Rate and Extent of Lymph Node Staging in Patients Undergoing Radical Prostatectomy May Undermine the Rate of Diagnosis of Lymph Node Metastases in Prostate Cancer.
Eur Urol. 2010 Sep 28. PMID: 20932637
Liberman D, Alasker A, Sun M, Ismail S, Lughezzani G, Jeldres C, Budaus L, Thuret R, Shariat SF, Widmer H, Perrotte P, Graefen M, Montorsi F, Karakiewicz PI.
Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based study.
BJU Int. 2010 Sep 22. doi: 10.1111/j.1464-410X.2010.09590.x. PMID: 20860649
Jeldres C, Sun M, Lughezzani G, Isbarn H, Shariat SF, Widmer H, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.
Highly predictive survival nomogram after upper urinary tract urothelial carcinoma.
Cancer. 2010 Aug 15;116(16):3774-84.PMID: 20564085
Ahyai SA, Zacharias M, Isbarn H, Steuber T, Eichelberg C, Köllermann J, Fisch M, Karakiewicz PI, Huland H, Graefen M, Chun FK.
Prognostic significance of a positive surgical margin in pathologically organ-confined prostate cancer.
BJU Int. 2010 Aug;106(4):478-83. Epub 2010 Jan 29.PMID: 20128781
Djavan B, Schlegel P, Salomon G, Eckersberger E, Sadri H, Graefen M.
Analysis of testosterone suppression in men receiving histrelin, a novel GnRH agonist for the treatment of prostate cancer.
Can J Urol. 2010 Aug;17(4):5265-71.PMID: 20735905
Auprich M, Haese A, Walz J, Pummer K, de la Taille A, Graefen M, de Reijke T, Fisch M, Kil P, Gontero P, Irani J, Chun FK.
External Validation of Urinary PCA3-Based Nomograms to Individually Predict Prostate Biopsy Outcome.
Eur Urol. 2010 Jul 3. PMID: 20619529 [PubMed - as supplied by
Isbarn H, Wanner M, Salomon G, Steuber T, Schlomm T, Köllermann J, Sauter G, Haese A, Heinzer H, Huland H, Graefen M.
Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.
BJU Int. 2010 Jul;106(1):37-43. Epub 2009 Dec 11.
Isbarn H, Karakiewicz PI, Vogel S, Jeldres C, Lughezzani G, Briganti A, Montorsi F, Perrotte P, Ahyai SA, Budäus L, Eichelberg C, Heuer R, Köllermann J, Sauter G, Schlomm T, Steuber T, Haese A, Zacharias M, Fisch M, Heinzer H, Huland H, Chun FK, Graefen M.
Unilateral prostate cancer cannot be accurately predicted in low-risk patients.
Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):784-7. Epub 2009 Oct 26.
Heidenreich A, Albers P, Classen J, Graefen M, Gschwend J, Kotzerke J, Krege S, Lehmann J, Rohde D, Schmidberger H, Uder M, Zeeb H; Association of Urologic Oncology of the German Cancer Society.
Imaging studies in metastatic urogenital cancer patients undergoing systemic therapy: recommendations of a multidisciplinary consensus meeting of the Association of Urological Oncology of the German Cancer Society.
Urol Int. 2010 Jul;85(1):1-10. Epub 2010 Jul 26. Review.
Graefen M.
Low quality of evidence for robot-assisted laparoscopic prostatectomy: a problem not only in the robotic literature.
Eur Urol. 2010 Jun;57(6):938-40; discussion 943-4. Epub 2010 Feb 12
Murphy DG, Bjartell A, Ficarra V, Graefen M, Haese A, Montironi R, Montorsi F, Moul JW, Novara G, Sauter G, Sulser T, van der Poel H.
Downsides of robot-assisted laparoscopic radical prostatectomy: limitations and complications.
Eur Urol. 2010 May;57(5):735-46. Epub 2009 Dec 28.
Lughezzani G, Budäus L, Isbarn H, Sun M, Perrotte P, Haese A, Chun FK, Schlomm T, Steuber T, Heinzer H, Huland H, Montorsi F, Graefen M, Karakiewicz PI.
Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.
Eur Urol. 2010 Apr;57(4):562-8. Epub 2009 Dec 10.
Jeldres C, Lughezzani G, Sun M, Isbarn H, Shariat SF, Budaus L, Lattouf JB, Widmer H, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.
Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter.
J Urol. 2010 Apr;183(4):1324-9. Epub 2010 Feb 19.
Ahyai SA, Isbarn H, Karakiewicz PI, Chun FK, Reichert M, Walz J, Steuber T, Jeldres C, Schlomm T, Heinzer H, Salomon G, Budäus L, Perrotte P, Huland H, Graefen M, Haese A.
The presence of prostate cancer on saturation biopsy can be accurately predicted.
BJU Int. 2010 Mar;105(5):636-41. Epub 2009 Jul 7.
Isbarn H, Karakiewicz PI, Ahyai SA, Chun FK, Jeldres C, Haese A, Heinzer H, Zacharias M, Heuer R, Eichelberg C, Steuber T, Budäus L, Köllermann J, Salomon G, Schlomm T, Perrotte P, Fisch M, Huland H, Graefen M.
Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancer.
BJU Int. 2010 Mar;105(6):818-23. Epub 2009 Sep 14.
Lughezzani G, Jeldres C, Isbarn H, Sun M, Shariat SF, Widmer H, Arjane P, Graefen M, Perrotte P, Montorsi F, Karakiewicz PI.
Temporal stage and grade migration in surgically treated patients with upper tract urothelial carcinoma.
BJU Int. 2010 Mar;105(6):799-804. Epub 2009 Sep 2.
Minner S, Jessen B, Stiedenroth L, Burandt E, Köllermann J, Mirlacher M, Erbersdobler A, Eichelberg C, Fisch M, Brümmendorf TH, Bokemeyer C, Simon R, Steuber T, Graefen M, Huland H, Sauter G, Schlomm T.
Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer.
Clin Cancer Res. 2010 Mar 1;16(5):1553-60. Epub 2010 Feb 23.
Graefen M.
The modified Clavien system: a plea for a standardized reporting system for surgical complications.
Eur Urol. 2010 Mar;57(3):387-9. Epub 2009 Dec 14.
Graefen M.
Editorial comment on: Cost comparison of robotic, laparoscopic and open radical prostatectomy for prostate cancer.
Eur Urol. 2010 Mar;57(3):458. Epub 2009 Nov 11.
Sun M, Lughezzani G, Alasker A, Isbarn H, Jeldres C, Shariat SF, Budäus L, Lattouf JB, Valiquette L, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.
Comparative study of inguinal hernia repair after radical prostatectomy, prostate biopsy, transurethral resection of the prostate or pelvic lymph node dissection.
J Urol. 2010 Mar;183(3):970-5. Epub 2010 Jan 18.
Isbarn H, Kellermann S, Salomon G, Steuber T, Huland H, Graefen M.
Type and extent of preoperative imaging before radical prostatectomy.
Urologe A. 2010 Mar;49(3):396-400.
Baillargeon-Gagné S, Jeldres C, Lughezzani G, Sun M, Isbarn H, Capitanio U, Shariat SF, Crépel M, Alasker A, Widmer H, Arjane P, Patard JJ, Perrotte P, Montorsi F, Graefen M, Karakiewicz PI.
A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma.
BJU Int. 2010 Feb;105(3):359-64.
Walz J, Burnett AL, Costello AJ, Eastham JA, Graefen M, Guillonneau B, Menon M, Montorsi F, Myers RP, Rocco B, Villers A.
A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy.
Eur Urol. 2010 Feb;57(2):179-92. Epub 2009 Nov 11.
Bhojani N, Capitanio U, Suardi N, Jeldres C, Isbarn H, Shariat SF, Graefen M, Arjane P, Duclos A, Lattouf JB, Saad F, Valiquette L, Montorsi F, Perrotte P, Karakiewicz PI.
The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients.
Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):342-8.
Börgermann C, Loertzer H, Hammerer P, Fornara P, Graefen M, Rübben H.
[Problems, objective, and substance of early detection of prostate cancer].
Urologe A. 2010 Feb;49(2):181-9.
Jeldres C, Sun M, Isbarn H, Lughezzani G, Budäus L, Alasker A, Shariat SF, Lattouf JB, Widmer H, Pharand D, Arjane P, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.
A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma.
Urology. 2010 Feb;75(2):315-20. Epub 2009 Dec 6.
Crépel M, Jeldres C, Perrotte P, Capitanio U, Isbarn H, Shariat SF, Liberman D, Sun M, Lughezzani G, Arjane P, Widmer H, Graefen M, Montorsi F, Patard JJ, Karakiewicz PI.
Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.
Urology. 2010 Feb;75(2):271-5. Epub 2009 Dec 4.
Isbarn H, Kellermann S, Salomon G, Steuber T, Huland H, Graefen M.
Type and extent of preoperative imaging before radical prostatectomy.
Urologe A. 2010 Jan 13.
El Gammal AT, Brüchmann M, Zustin J, Isbarn H, Hellwinkel OJ, Köllermann J, Sauter G, Simon R, Wilczak W, Schwarz J, Bokemeyer C, Brümmendorf TH, Izbicki JR, Yekebas E, Fisch M, Huland H, Graefen M, Schlomm T.
Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer.
Clin Cancer Res. 2010 Jan 1;16(1):56-64.
Steuber T, Schlomm T, Heinzer H, Zacharias M, Ahyai S, Chun KF, Haese A, Klutmann S, Köllermann J, Sauter G, Mester J, Mikecz P, Fisch M, Huland H, Graefen M, Salomon G.
[F(18)]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study.
Eur J Cancer. 2010 Jan;46(2):449-55. Epub 2009 Dec 5.
Lughezzani G, Jeldres C, Isbarn H, Shariat SF, Sun M, Pharand D, Widmer H, Arjane P, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.
A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma.
Urology. 2010 Jan;75(1):118-24. Epub 2009 Oct 28.
